巴菲特追随者Eoysne personal page - To The Moon

巴菲特追随者Eoysne

巴菲特追随者Eoysne

头顶三尺思盈利，探索利益新路子！专注研究趋势、前景和未来！

104Follow

143Followers

0Topic

0Badge

巴菲特追随者Eoysne

2023-08-29

$燃料电池能源(FCEL)$

巴菲特追随者Eoysne

2023-04-14

$Petros Pharmaceuticals Inc(PTPI)$ It's so beautiful[财迷] [财迷] $Faraday Future(FFIE)$ $特斯拉(TSLA)$

巴菲特追随者Eoysne

2021-01-28

$Sundial Growers Inc.(SNDL)$Target price 5 USD

巴菲特追随者Eoysne

2021-01-28

$Sundial Growers Inc.(SNDL)$Come on！frends?

巴菲特追随者Eoysne

2020-09-14

$Vaxart, Inc(VXRT)$Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3521004105479987","uuid":"3521004105479987","gmtCreate":1558003137588,"gmtModify":1617202222340,"name":"巴菲特追随者Eoysne","pinyin":"bftzszeoysnebafeitezhuisuizheeoysne","introduction":"","introductionEn":"","signature":"头顶三尺思盈利，探索利益新路子！专注研究趋势、前景和未来！","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":143,"headSize":104,"tweetSize":146,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":5,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.10","exceedPercentage":"80.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":214141762625736,"gmtCreate":1693321541263,"gmtModify":1693321541302,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ &nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ &nbsp;</a>","text":"$燃料电池能源(FCEL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/214141762625736","isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":651325643,"gmtCreate":1681487170283,"gmtModify":1681487170283,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTPI\">$Petros Pharmaceuticals Inc(PTPI)$ &nbsp;</a>It's so beautiful[财迷]&nbsp;[财迷]&nbsp;<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$&nbsp;</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/PTPI\">$Petros Pharmaceuticals Inc(PTPI)$ &nbsp;</a>It's so beautiful[财迷]&nbsp;[财迷]&nbsp;<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$&nbsp;</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a>","text":"$Petros Pharmaceuticals Inc(PTPI)$ It's so beautiful[财迷] [财迷] $Faraday Future(FFIE)$ $特斯拉(TSLA)$","images":[{"img":"https://static.tigerbbs.com/b3815fb62afc65b602f6b75e1f74c0a5","width":"2396","height":"3539"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/651325643","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":311634648,"gmtCreate":1611789255084,"gmtModify":1704863519334,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Target price 5 USD","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Target price 5 USD","text":"$Sundial Growers Inc.(SNDL)$Target price 5 USD","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311634648","isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311639955,"gmtCreate":1611788495077,"gmtModify":1704863511954,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Come on！frends?","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Come on！frends?","text":"$Sundial Growers Inc.(SNDL)$Come on！frends?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311639955","isVote":1,"tweetType":1,"viewCount":259,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":972312867,"gmtCreate":1600096784160,"gmtModify":1705063322465,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","listText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","text":"$Vaxart, Inc(VXRT)$Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/972312867","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":663816444,"gmtCreate":1663080505390,"gmtModify":1676537198963,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a><a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>","listText":"<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$</a><a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>","text":"$Faraday Future(FFIE)$$特斯拉(TSLA)$$蔚来(NIO)$","images":[{"img":"https://static.tigerbbs.com/c1c20b24ee18be0b80aafbbe2757dc31","width":"1176","height":"2400"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/663816444","isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":311634648,"gmtCreate":1611789255084,"gmtModify":1704863519334,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Target price 5 USD","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Target price 5 USD","text":"$Sundial Growers Inc.(SNDL)$Target price 5 USD","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311634648","isVote":1,"tweetType":1,"viewCount":104,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311639955,"gmtCreate":1611788495077,"gmtModify":1704863511954,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Come on！frends?","listText":"<a href=\"https://laohu8.com/S/SNDL\">$Sundial Growers Inc.(SNDL)$</a>Come on！frends?","text":"$Sundial Growers Inc.(SNDL)$Come on！frends?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311639955","isVote":1,"tweetType":1,"viewCount":259,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":651325643,"gmtCreate":1681487170283,"gmtModify":1681487170283,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTPI\">$Petros Pharmaceuticals Inc(PTPI)$ &nbsp;</a>It's so beautiful[财迷]&nbsp;[财迷]&nbsp;<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$&nbsp;</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/PTPI\">$Petros Pharmaceuticals Inc(PTPI)$ &nbsp;</a>It's so beautiful[财迷]&nbsp;[财迷]&nbsp;<a href=\"https://laohu8.com/S/FFIE\">$Faraday Future(FFIE)$&nbsp;</a><a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$&nbsp;</a>","text":"$Petros Pharmaceuticals Inc(PTPI)$ It's so beautiful[财迷] [财迷] $Faraday Future(FFIE)$ $特斯拉(TSLA)$","images":[{"img":"https://static.tigerbbs.com/b3815fb62afc65b602f6b75e1f74c0a5","width":"2396","height":"3539"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/651325643","isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":972312867,"gmtCreate":1600096784160,"gmtModify":1705063322465,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","listText":"<a href=\"https://laohu8.com/S/VXRT\">$Vaxart, Inc(VXRT)$</a>Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","text":"$Vaxart, Inc(VXRT)$Press Release DetailsVaxart Announces FDA Clearance of IND Application for Oral ** Vaccine and Provides Update on ** ProgramSeptember 14, 2020 at 8:00 AM EDTPDF VersionRecruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN FRANCISCO, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral ** vaccine candidate. The Company also provi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/972312867","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":214141762625736,"gmtCreate":1693321541263,"gmtModify":1693321541302,"author":{"id":"3521004105479987","authorId":"3521004105479987","name":"巴菲特追随者Eoysne","avatar":"https://static.tigerbbs.com/66924ccc9b53334d0c73d4dfc2c5adf2","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3521004105479987","authorIdStr":"3521004105479987"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ &nbsp;</a>","listText":"<a href=\"https://laohu8.com/S/FCEL\">$燃料电池能源(FCEL)$ &nbsp;</a>","text":"$燃料电池能源(FCEL)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/214141762625736","isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}